Anterix
ATEX
100 hedge funds and large institutions have $567M invested in Anterix in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 49 increasing their positions, 23 reducing their positions, and 9 closing their positions.
14,271% more call options, than puts
Call options by funds: $1.01M | Put options by funds: $7K
113% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 23
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
6% more funds holding
Funds holding: 94 → 100 (+6)
3.99% more ownership
Funds ownership: 79.62% → 83.62% (+4%)
9% less capital invested
Capital invested by funds: $621M → $567M (-$53.4M)
Top Buyers
| 1 |
BlackRock
New York
|
+$12.7M |
| 2 |
HCL
Heard Capital LLC
Chicago,
Illinois
|
+$9.98M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.73M |
| 4 |
ClearBridge Investments
New York
|
+$2.55M |
| 5 |
Goldman Sachs
New York
|
+$2.4M |
Top Sellers
ATEX Hedge Fund Activity: Q3 2022 in Review
100 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Anterix (ATEX) for Q3 2022, worth a combined $567M — down 8.6% from $621M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new ATEX positions and 9 closed out — a net gain of 7 holders — while 49 added to existing stakes and 23 trimmed.
The largest buyer was BlackRock, adding an estimated $12.7M. The largest seller was Jennifer C. Price, cutting an estimated $5.03M.
- 100 institutional investors held Anterix (ATEX) as of Q3 2022, up from 94 in Q2 2022.
- Funds reported $567M of Anterix stock for Q3 2022, down 8.6% quarter-over-quarter.
- 16 funds opened new Anterix positions in Q3 2022 and 9 closed out, a net change of +7 holders.
- The largest Anterix buyer in Q3 2022 was BlackRock, an estimated $12.7M added.
- The largest Anterix seller in Q3 2022 was Jennifer C. Price, an estimated $5.03M sold.
Based on aggregated 13F filings for Q3 2022.